• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.36% Nasdaq Up0.45%

    Fate Therapeutics, Inc. (FATE)

    -NGM
    6.23 Up 0.25(4.18%) 4:00PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (25,883) (20,894) (14,239)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation520  965  674  
    Adjustments To Net Income2,927  4,249  291  
    Changes In Accounts Receivables -   -   -  
    Changes In Liabilities163  1,578  405  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(146)(1,271)(405)
    Total Cash Flow From Operating Activities (22,419) (15,373) (13,274)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(882)(244)(709)
    Investments -   -   -  
    Other Cash flows from Investing Activities -  6   -  
    Total Cash Flows From Investing Activities (882) (238) (709)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock142  40,503  16,933  
    Net Borrowings18,224  20,057  (250)
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 18,366   60,560   16,683  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents (4,935) 44,949   2,700  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.